Advertisement Activplant signs framework agreement with GSK - Pharmaceutical Business review
Pharmaceutical Business review is using cookies

ContinueLearn More
Close

Activplant signs framework agreement with GSK

Activplant, a provider of enterprise manufacturing intelligence solutions, has announced that GlaxoSmithKline has signed a global framework agreement naming Activplant as a recommended business intelligence solution for its worldwide manufacturing sites.

The agreement comes after a successful implementation where GlaxoSmithKline (GSK) experienced the ease of use that empowers operators, engineers and management to positively affect their overall equipment effectiveness (OEE), and consequently, their production costs.

Activplant’s Throughput Analyzer software product is currently implemented within key GSK facilities in North America and the UK.

Julian Ward, application champion of GSK, said: “Once we saw how quickly Activplant’s Throughput Analyzer could be implemented and drive results in our facility in North Carolina, we felt that it made sense to negotiate a global framework agreement to reduce complexity where our facilities wish to consider implementing OEE projects.”